New eye drop aims to lower pressure in glaucoma without raising heart risks
NCT ID NCT06030193
First seen Feb 05, 2026 · Last updated May 20, 2026 · Updated 14 times
Summary
This study tested a new eye drop called QLS-111 in 37 adults with normal tension glaucoma, a type of glaucoma where eye pressure is not very high but still damages the optic nerve. The goal was to see if QLS-111 is safe and tolerable compared to a standard eye drop (timolol). Researchers measured side effects and how well each drop lowered eye pressure throughout the day.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, 3080, South Korea
Conditions
Explore the condition pages connected to this study.